Full-Time

Senior Control Engineer Lead

Ottobock

Ottobock

1,001-5,000 employees

Provider of prosthetics, orthotics, wheelchairs, exoskeletons

No salary listed

Germany

Hybrid

Remote within Germany; occasional on-site visits in Duderstadt may be required.

Category
Electrical Engineering (1)

Get referred to Ottobock

See people who can refer or advise you

Requirements
  • Very good command of English and good ability to communicate in German
Responsibilities
  • You also handle processes related to patent evaluations and invention disclosures
Desired Qualifications
  • Having prior knowledge in wearable robotics, orthotics or prosthetics is advantageous but not required

Ottobock is a global producer of orthopedic technology, focusing on prosthetics, orthotics, wheelchairs, and exoskeletons. Its products range from basic devices to advanced, microprocessor-controlled prosthetics and ergonomic exoskeletons that help people move more easily and stay independent. These devices work by using sensors, motors, and smart controls to adapt to a user’s movement, pace, and terrain, providing ankle and knee assistance or full upper- and lower-limb support. compared with others, Ottobock stands out as a family-owned company with a long history, a broad international footprint in about 60 countries, a large workforce, and a strong commitment to social responsibility, including a long-running partnership with the Paralympic Games. Its core goal is to improve mobility and quality of life for people with disabilities by delivering reliable, high-quality mobility solutions.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Duderstadt, Germany

Founded

1919

Get referred to Ottobock

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 core revenue rose 5.1% to €378.4 million; guidance stayed intact.
  • Free cash flow jumped 32% to €41.5 million, while leverage fell to 2.2x.
  • Ottobock invested $5 million in Blue Arbor and released #DearAI on Hugging Face.

What critics are saying

  • Grizzly Research's May 2026 short report triggered stock volatility and BaFin market-manipulation scrutiny.
  • Reuters said the Näder family still owes roughly €1 billion, maturing by Q1 2030.
  • Russia operations and aggressive-accounting accusations threaten financing, customer trust, and IPO valuation.

What makes Ottobock unique

  • Ottobock leads global prosthetics, neuro-orthotics, and exoskeletons from Duderstadt, Germany.
  • Its 2026 Fesia Technology acquisition adds functional electrical stimulation for neurological patients.
  • The Blue Arbor RESTORE investment extends implanted neural control beyond standard socket prosthetics.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

401(k) Company Match

100% company-paid short & long-term disability

Company News

PR Newswire
Jul 22nd, 2026
Ottobock releases community-built AI image library to improve representation of people with limb loss

Ottobock has released the #DearAI Community Library, one of the first open-source image datasets depicting people with limb loss and limb differences in everyday life. The library, powered by Microsoft and now available on Hugging Face, was created and annotated by the community itself to address AI's lack of disability representation. Research across 444 AI-generated images found not a single person with visible disability appeared in 37 occupations. When disability does appear, nearly 100% default to wheelchair depictions, making prosthetic users effectively invisible. An international group of Ottobock prosthetic users worked within Microsoft's Community Library Creator to select and annotate images against community-defined standards. The result includes two datasets covering upper and lower limb differences, showing people as parents, colleagues, athletes and community members. The library is freely accessible to researchers, developers, brands and creators at huggingface.co/ottobock.

AD HOC NEWS
Jul 7th, 2026
Ottobock acquires Spain's Fesia Technology to expand neuro-orthotics portfolio with FES systems

German MedTech company Ottobock is acquiring Spanish firm Fesia Technology to expand its neuro-orthotics portfolio. The deal, expected to close in approximately six months, will add functional electrical stimulation (FES) technology to Ottobock's product range. Financial terms were not disclosed. Fesia, based in Donostia/San Sebastián, employs around 20 people and develops FES systems for patients with neurological conditions including stroke, multiple sclerosis, cerebral palsy, and spinal cord injuries. The technology uses electrical impulses to stimulate weakened muscles and support the formation of new neural connections. Ottobock CEO Oliver Jakobi said neurological conditions are a major focus for the orthotics and prosthetics industry, with the number of affected people steadily increasing worldwide. The acquisition strengthens Ottobock's position as a global leader in neuro-orthotics whilst providing access to an innovative FES technology platform.

Yahoo Finance
May 14th, 2026
Ottobock's $268M free cash flow exceeds $104M profit amid strong earnings

Ottobock SE KGaA reported solid earnings supported by strong cash flow conversion. The company generated €237 million in free cash flow over the past twelve months, significantly exceeding its statutory profit of €91.8 million. The company's accrual ratio of -0.11 for the year to March 2026 indicates its free cash flow substantially surpassed reported earnings, which analysts consider a positive sign. However, unusual items worth €30 million reduced Ottobock's profit during the period. These one-time expenses contributed to the strong cash conversion metrics but are not expected to recur. Analysts suggest that without these unusual charges, Ottobock should deliver higher profits in the coming year, assuming other factors remain constant.

Morningstar
Feb 26th, 2026
Blue Arbor secures $5M from Ottobock to advance FDA breakthrough prosthetic control system

Blue Arbor Technologies has secured a $5 million investment from Ottobock, the global prosthetics leader, to advance its RESTORE Neuromuscular Interface System. Ottobock will lead Blue Arbor's Series A financing and hold a board seat. The FDA breakthrough-designated RESTORE System provides a fully implanted neuromuscular interface connecting advanced prostheses directly to patients' residual muscles and peripheral nerves. It enables independent, simultaneous control of fingers, wrist and elbow, with trials demonstrating stable signal capture for over five years. In December 2025, surgeons at the Medical University of Vienna completed the first-in-human RESTORE procedure. Within days, the patient demonstrated functional use with an Ottobock prosthetic. Founded by Drs Paul Cederna, Theodore Kung and Alex Vaskov, Blue Arbor has been awarded over $60 million in research grants and published more than 200 peer-reviewed papers.

Business Wire
Feb 26th, 2026
Blue Arbor Technologies Announces Strategic Partnership with Ottobock and $5 Million Investment to Advance RESTORE™ Neuromuscular Interface System

Blue Arbor Technologies announces $5 million investment by Ottobock to advance RESTORE™ System, designed to enable intuitive prosthetic control